Axona targets diminished cerebral glucose metabolism to effectively enhance memory and cognition*1

Add Axona to Alzheimer’s disease management, including drug treatments, to address multiple aspects of the disease at the same time1

Diminished cerebral glucose metabolism (DCGM, also known as glucose hypometabolism) occurs early in the disease and correlates with symptoms and disease progression.2-6 During times of DCGM, the brain can use alternative fuel sources, such as ketone bodies, to produce cellular energy.7,8

Axona is a medical food that increases the concentration of ketone bodies in the blood. Adding Axona to Alzheimer’s disease management addresses different aspects of the disease at the same time and may further enhance memory and cognition.*1